SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
SCMP
Delisted
SCMP was delisted on the 12th of February, 2018.
167 hedge funds and large institutions have $287M invested in Sucampo Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 57 increasing their positions, 47 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
16% less capital invested
Capital invested by funds: $340M → $287M (-$52.9M)
Holders
167
Holding in Top 10
1
Calls
$1.48M
Puts
$1.12M
Top Buyers
| 1 | +$39.2M | |
| 2 | +$10.3M | |
| 3 | +$5.72M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.26M |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$2.73M |
Top Sellers
| 1 | -$6.78M | |
| 2 | -$5.12M | |
| 3 | -$4.76M | |
| 4 |
TA
Teachers Advisors
New York
|
-$4.6M |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$3.85M |